Targeted naltrexone treatment of early problem drinkers

Addictive Behaviors
Henry R KranzlerMichael J Bohn

Abstract

Naltrexone is approved for daily use in the treatment of alcohol dependence. We evaluated the feasibility of using targeted naltrexone (i.e., on an "as-needed" basis) to treat early problem drinkers. Twenty-one subjects (52% male) received brief coping skills training weekly for 4 weeks, along with naltrexone (50 mg), which they were instructed to use 2 to 5 times per week in anticipation of high-risk drinking situations. During treatment, statistically and clinically significant declines were observed across a variety of drinking-related outcomes, including the intensity of drinking, the decline in which was correlated with medication use. Beneficial effects of the intervention were still evident during the 3-month posttreatment period. Further research, including a placebo-controlled evaluation of targeted naltrexone, is needed to determine the optimal treatment strategy for early problem drinkers, many of whom are seen in the primary-care medical setting.

References

Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Nov 1, 1992·Archives of General Psychiatry·J R VolpicelliC P O'Brien
Nov 1, 1992·Archives of General Psychiatry·S S O'MalleyB Rounsaville
Nov 1, 1987·Journal of Studies on Alcohol·M E Hilton, W B Clark
May 1, 1987·The International Journal of the Addictions·F Duckert, J Johnsen
Jun 1, 1995·Alcoholism, Clinical and Experimental Research·M J BohnB A Staehler
Dec 1, 1994·Journal of Consulting and Clinical Psychology·T F Babor
Oct 1, 1994·The American Journal of Psychiatry·R M SwiftH Hsuing
Mar 1, 1993·Addiction·T H BienJ S Tonigan
Nov 1, 1996·Alcoholism, Clinical and Experimental Research·F K Del BocaP F Korner

❮ Previous
Next ❯

Citations

Nov 15, 2001·Current Psychiatry Reports·G O'LearyR D Weiss
Jul 25, 2013·CNS Drugs·Mark J Niciu, Albert J Arias
Jul 28, 1999·European Journal of Pharmacology·P BienkowskiE Koros
Dec 3, 1999·Progress in Neuro-psychopharmacology & Biological Psychiatry·M S Cowen, A J Lawrence
Dec 24, 2002·Journal of Substance Abuse Treatment·Gabriel RubioTomás Palomo
Apr 7, 2004·Journal of Consulting and Clinical Psychology·Henry R KranzlerHoward Tennen
Jul 14, 2009·Journal of Clinical Psychopharmacology·Henry R KranzlerCheryl Oncken
Mar 3, 2005·Neuropsychobiology·Giovanni AddoloratoGiovanni Gasbarrini
Jan 1, 2007·Indian Journal of Psychiatry·Sandeep GroverGaurav Bhateja
Feb 28, 2014·CNS Drugs·Carolina L Haass-KofflerGeorge A Kenna
Jun 10, 2011·Expert Opinion on Investigational Drugs·Thomas HillemacherHelge Frieling
Apr 20, 2012·Drug and Alcohol Dependence·Teresa R FranklinAnna Rose Childress
Mar 27, 2003·Alcoholism, Clinical and Experimental Research·Janice FroehlichConor Farren
Apr 26, 2006·Alcoholism, Clinical and Experimental Research·Carlos A Hernandez-AvilaHenry R Kranzler
Feb 13, 2013·Alcoholism, Clinical and Experimental Research·Rachel A HayDonita L Robinson
Mar 21, 2000·The American Journal of Medicine·D A FiellinP G O'Connor
Feb 20, 2004·The American Journal on Addictions·Raymond F Anton, Robert M Swift
Apr 9, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Antoni GualUNKNOWN ESENSE 2 Study Group
Jan 27, 2016·Expert Opinion on Pharmacotherapy·Michael Soyka
Jan 6, 2017·Alcoholism, Clinical and Experimental Research·Janice C FroehlichLogan C Rademacher
Feb 11, 2016·Journal of Psychopharmacology·Fabio CaputoMauro Bernardi
Nov 20, 2004·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Jorge ManzanaresTomás Palomo
Nov 28, 2002·Journal of Clinical Psychopharmacology·Markus GastparRobert Croop
Jun 27, 2003·Journal of Clinical Psychopharmacology·Henry R KranzlerRichard Feinn
May 25, 2020·Mayo Clinic Proceedings·Jeremiah FairbanksShirshendu Sinha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Psychopharmacology
Henry R KranzlerCheryl Oncken
Journal of Clinical Psychopharmacology
Henry R KranzlerRichard Feinn
Journal of American College Health : J of ACH
Amee J EplerStephanie S O'Malley
© 2021 Meta ULC. All rights reserved